Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Benefits (Research Focus) NNMT inhibition studied as a selective small-molecule inhibitor of nicotinamide N-methyltransferase NAD+ preservation investigated for preservation of cellular NAD+ pools and downstream sirtuin pathway activity Adipose tissue research explored for lipolysis markers and fat-mass partitioning in DIO rodent models Skeletal muscle metabolism examined for endpoints related to muscle aging and sarcopenia models Metabolic signaling researched for glucose homeostasis and insulin sensitivity endpoints in metabolic disease models What Researchers Look At NNMT enzymatic activity and 1-methylnicotinamide (1-MNA) tissue concentrations Intracellular NAD+ / NADH ratio and downstream sirtuin (SIRT1/SIRT3) activation Body composition, fat mass, and lean mass partitioning in DIO rodent models Adipocyte lipolysis markers and adipose tissue inflammation profiles Glucose tolerance, insulin sensitivity, and hepatic steatosis endpoints Quick Specs Form: Lyophilized white powder Net Content: 10 mg per vial (as iodide salt) Quantity: 1 vial Appearance: White to off-white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound: 5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) Synonyms: 5-Amino-1-methylquinolinium
Co-immunoprecipitation studies demonstrated that the peptide reduces eNOS/caveolin-1 binding by approximately 50%, effectively doubling the available eNOS for nitric oxide production
In tendons and ligaments, peptides for injury recovery stimulate fibroblasts to produce more collagen and organize it into stronger, more functional structures
-30% OLIMP Lutein Max-Complex / 30 Tabs 8.59 / 16.80
UsesDirections for UseRoute of AdministrationSide EffectsMedicine ActivityPrecautions & WarningsInteractionsDosageStorageSpecial Dietary And Lifestyle RecommendationFact BoxFAQs KARNITINE INJECTION 5ML is used for the following: Primary and secondary carnitine deficiency, particularly in patients with end-stage renal disease undergoing haemodialysis As supportive therapy in certain fatigue-related conditions To use KARNITINE INJECTION 5ML, follow the instructions below: It should only be administered under the supervision of a healthcare professional
